GlassScriptPhysician profile
Richard D Palmer
NPI 1396742128
$12,515.09
in general payments reported to CMS, 2019-2025
58 companies · $1,837 in 2025
The $1,837 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $1,463 · 2021: $1,594 · 2022: $1,916 · 2023: $2,008 · 2024: $2,257 · 2025: $1,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,101.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,169.90 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,808.77 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,454.73 | 2019-2025 | |
| Lilly USA, LLC | $984.92 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $864.45 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $471.25 | 2022-2025 | Caplyta |
| Pfizer INC. | $440.60 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.68 | 2019-2024 | Ofev |
| Allergan, INC. | $395.17 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $301.85 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $301.79 | 2019-2025 | Gardasil 9, Capvaxive, Dificid |
| Shield Therapeutics INC | $275.46 | 2023-2025 | Accrufer |
| Amarin Pharma, INC. | $196.08 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $172.81 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $162.98 | 2021-2022 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $154.10 | 2019-2022 | |
| Abbott Laboratories | $152.69 | 2023-2024 | Freestyle Libre 3, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.79 | 2019-2024 | Xifaxan |
| Amgen INC. | $134.23 | 2019-2024 | Repatha, Otezla |
| Dexcom, INC. | $103.70 | 2025 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $100.57 | 2021-2025 | Nexletol |
| Axsome Therapeutics, INC. | $91.78 | 2025 | Symbravo, Auvelity |
| Viiv Healthcare Company | $88.70 | 2024-2025 | Apretude |
| Idorsia Pharmaceuticals US INC | $67.36 | 2022-2023 | Quviviq |
| Corcept Therapeutics | $65.29 | 2021-2025 | Korlym |
| Supernus Pharmaceuticals, INC. | $64.62 | 2025 | Qelbree |
| Exact Sciences Corporation | $60.98 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $59.78 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $54.38 | 2023-2024 | Gemtesa |
| Genentech USA, INC. | $51.60 | 2020 | |
| Astellas Pharma US INC | $44.85 | 2019-2022 | |
| Tris Pharma INC | $44.32 | 2023 | Dyanavel Xr |
| Dynavax Technologies Corporation | $43.08 | 2023-2025 | Heplisav-B |
| Eisai INC. | $42.54 | 2021 | |
| Sanofi Pasteur INC. | $41.88 | 2021-2022 | |
| Alk-Abello, INC | $39.62 | 2019-2023 | Ragwitek, Grastek, Odactra |
| Biohaven Pharmaceutical Holding Company LTD. | $37.44 | 2022 | |
| Nestle Healthcare Nutrition INC. | $36.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.48 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $27.14 | 2021-2024 | Abilify Maintena, Rexulti |
| Bausch Health US, LLC | $25.60 | 2021 | |
| Shire North American Group INC | $25.58 | 2019 | |
| Phadia US INC. | $23.50 | 2025 | Immunocap |
| Becton, Dickinson and Company | $23.43 | 2023 | Bd Affirm Vpiii Microbial Identification Test |
| Lundbeck LLC | $21.98 | 2025 | Rexulti |
| Philips North America LLC | $21.46 | 2024 | (Ck7) Extended Holter |
| Kaleo, INC. | $18.34 | 2022 | |
| Si-Bone, INC. | $16.65 | 2021 | |
| Corium, LLC | $15.77 | 2022 | |
| Adlon Therapeutics L.P. | $15.74 | 2020 | |
| Mannkind Corporation | $15.58 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.25 | 2024 | |
| Althera Pharmaceuticals LLC | $15.18 | 2021 | |
| Optinose US, INC. | $14.97 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.68 | 2024 | Ajovy |
| Azurity Pharmaceuticals, INC. | $14.43 | 2023 | Edarbi |
| Medtronic, INC. | $14.41 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.